Critical molecular pathways in CLL therapy
Abstract Chronic lymphocytic leukemia (CLL), the most frequent type of leukemia in western countries, is characterized by the progressive accumulation in blood, bone marrow and lymphoid tissues of monoclonal B lymphocytes with a characteristic immunophenotype. Despite advances in therapy and improve...
Saved in:
Main Authors: | Gerardo Ferrer (Author), Emili Montserrat (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2018-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapy of chronic lymphocytic leukemia (CLL) - from past to present
by: Anna Gumieniczek, et al.
Published: (2020) -
Potential New Therapies "ROS-Based" in CLL: An Innovative Paradigm in the Induction of Tumor Cell Apoptosis
by: Raffaele Sciaccotta, et al.
Published: (2024) -
Targeted therapies in CLL/SLL and the cumulative incidence of infection: A systematic review and meta-analysis
by: Stephanos Vassilopoulos, et al.
Published: (2022) -
Non-Coding RNAs: The "Dark Side Matter" of the CLL Universe
by: Marcello Francesco Lingua, et al.
Published: (2021) -
Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL
by: Annamaria Mascolo, et al.
Published: (2023)